During the past decade, Northwest Neurological, PLLC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Neurological, PLLC" #1 sponsor was "Athira Pharma" with 1 trials, followed by "Biogen" with 1 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored, "Michael Alan Schwarzschild" with 1 trials sponsored and "University of Rochester" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Neurological, PLLC" #1 collaborator was "Michael J. Fox Foundation for Parkinson's Research" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "National Parkinson Foundation" with 1 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator and "The Parkinson Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Neurological, PLLC" are "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials), "Dementia of Alzheimer Type" (1 trials), "Migraine" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Northwest Neurological, PLLC" in a lesser frequency.

Most popular intervention types in "Northwest Neurological, PLLC" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ATH-1017" (1 trials), "Aducanumab (BIIB037)" (1 trials), "Eptinezumab" (1 trials) and "Inosine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Neurological, PLLC" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Neurological, PLLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Northwest Neurological, PLLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Neurological, PLLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".